Streetbeat News

Products Services

VRCA

WBA

Verrica Pharmaceuticals has entered into a specialty pharmacy partnership with Walgreens for the distribution of YCANTH. This agreement could potentially enhance the accessibility and distribution of YCANTH, which may positively impact Verrica Pharmaceuticals' market reach and sales.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:38 pm

SLS

SELLAS Life Sciences Group, Inc. has provided updates on its corporate activities and outlined key milestones for 2024. These include interim analysis of the Phase 3 REGAL study of Galinpepimut-S in Acute Myeloid Leukemia (AML) patients expected in Q1 2024, topline data from a Phase 2a study of SLS009 in relapsed/refractory AML patients also expected in Q1 2024, and topline data from a Phase 1b/2 study in relapsed/refractory Peripheral T-cell Lymphoma patients expected in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:35 pm

AAPL

Apple Inc. (NASDAQ:AAPL) has been granted a patent for a new feature for the Vision Pro's external display, which could show what the wearer is seeing or other animations. This innovation comes amid rumors of a display overhaul for the Vision Pro 2 and the anticipated launch of the $3,500 Vision Pro headset in the last week of January, earlier than expected.

Portfolio Pulse from Rounak Jain

January 03, 2024 | 12:32 pm

NCNO

Camden National Bank has implemented advanced mortgage origination and closing solutions provided by nCino, aiming to enhance the mortgage process for its customers. This adoption could streamline operations and improve customer experience, potentially leading to increased efficiency and customer satisfaction for Camden National Bank.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:31 pm

S

SentinelOne, a cybersecurity firm, has announced the acquisition of PingSafe, an AI-driven cloud security company. This move is aimed at expanding SentinelOne's cloud security capabilities. The financial terms of the deal have not been disclosed. SentinelOne's stock, which trades under the ticker symbol S, may be influenced by this strategic acquisition as it enhances the company's product offerings in the cloud security space.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:22 pm

HROW

Harrow Health, Inc. has partnered with three healthcare technology platforms to expand the availability of VEVYE, its ophthalmic solution, in the United States. This strategic move aims to enhance patient access to VEVYE through innovative distribution channels.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:15 pm

VIRI

Virios Therapeutics, in a letter to shareholders, announced that they are exploring options to advance their IMC-1 LC Investigational New Drug Application and its proposed Phase 2 research program.

Portfolio Pulse from Charles Gross

January 03, 2024 | 12:11 pm

AEVA

Aeva, a company specializing in LiDAR technology, has been chosen by an unnamed global automotive OEM to supply its LiDAR sensors for a series production program. This partnership marks a significant milestone for Aeva, as it secures a direct supply deal with a major car manufacturer, potentially boosting its market presence and credibility in the automotive industry.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:11 pm

LEAS

SEALSQ announced the launch of SEALCOIN, a new digital token and advanced cryptocurrency protocol, at the Davos Space IoT and Cybersecurity event on January 17. This development could signal SEALSQ's entry into the blockchain and cryptocurrency market, potentially expanding its business model and offerings.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:09 pm

APLT

Applied Therapeutics announced the validation of its Marketing Authorization Application (MAA) and the submission of a New Drug Application (NDA) for Govorestat (AT-007) for the treatment of Classic Galactosemia. The submissions are based on positive results from the Phase 3 ACTION-Galactosemia Kids study.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 12:08 pm